Study finds breast cancer risk not connected to insulin

09/4/2013 |

The use of various insulin types was not linked to breast cancer risk in women with diabetes regardless of dosage, duration of use and tumor stage, a study in Diabetes Care indicated. Data showed the odds ratio of breast cancer after 3.2 years of insulin use was 1.04 for patients who used glargine, 1.23 for those who took lispro, 0.95 for those who used aspart and 0.81 for those on human insulin.

View Full Article in:

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
In house Compliance Officer
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC